AstraZeneca's admission of potential side effects has led to legal deliberations by families affected by Covishield. Concerns raised after Venugopalan Govindan's daughter's death prompt reevaluation of vaccine safety and accountability. Regulatory scrutiny intensifies globally as the Covishield saga unfolds, emphasizing the imperative of transparency and justice in public health crises.